Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04235725 · ClinicalTrials.gov registry record
Implementation of Harmonized Depression Outcome Measures in a Primary Care Registry and a Mental Health Registry
A clinical trial of Major Depression and Dysthymia, sponsored by OM1.
- Completed
- Registry status
- 953
- Enrollment target
- 2
- Study locations
NCT04235725: Completed study of Major Depression and Dysthymia, sponsored by OM1.
NCT04235725 is a study of Major Depression and Dysthymia that has completed, run by OM1. The registered enrollment target is 953 participants, above the 293-participant average among 28 other Major Depression trials with a reported enrollment target (225% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04235725, a study of Major Depression and Dysthymia, has completed, sponsored by OM1.
- COMPLETED
- Registry status
- 953 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this pilot project is to demonstrate feasibility and value of collecting harmonized outcomes measures for major depressive disorder (MDD) in two registries and combining the data to support patient-centered outcomes research.
Primary Outcome
Patient age 18 or older with a diagnosis of major depression or dysthymia who died from suicide.
Conditions Studied
Interventions
- OTHER Harmonized Depression Outcome Measures
Study Locations (2)
District of Columbia
- American Psychiatric Association - Washington D.C.
Kentucky
- American Board of Family Medicine - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 953 participants |
| Start Date | 2020-03-15 |
| Est. Completion | 2021-05-15 |
What the finished NCT04235725 record still lists
NCT04235725 is an observational study that tracks outcomes without assigning an intervention. The registered 953 participants enrollment target is mid-sized for trials with a published cap, above the 293-participant average among 28 other Major Depression trials with a reported enrollment target (225% higher).
The record links to 2 conditions, with Major Depression appearing as the primary indexed condition, and to 1 intervention - of which Harmonized Depression Outcome Measures is the first listed.
NCT04235725 reports a single indexed study location in District of Columbia, Kentucky.
Frequently Asked Questions
What is clinical trial NCT04235725 about?
NCT04235725 is a clinical study titled "Implementation of Harmonized Depression Outcome Measures in a Primary Care Registry and a Mental Health Registry". The purpose of this pilot project is to demonstrate feasibility and value of collecting harmonized outcomes measures for major depressive disorder (MDD) in two registries and combining the data to support patient-centered outcomes research.
What is the current status of trial NCT04235725?
This trial is currently completed. The enrollment target is 953 participants. The study started on 2020-03-15. Estimated completion is 2021-05-15.
What conditions does trial NCT04235725 study?
This clinical trial studies the following conditions: Major Depression, Dysthymia.
What interventions are being tested in trial NCT04235725?
The interventions under investigation include: Harmonized Depression Outcome Measures (OTHER).
Who is sponsoring clinical trial NCT04235725?
This trial is sponsored by OM1, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04235725 being conducted?
This trial has 2 study locations across District of Columbia, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04235725's enrollment target sits among peer trials
953 4th of 28 higher than 25 of 28 other Major Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Major Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
RECRUITING · Phase 1
-
University of Iowa Interventional Psychiatry Service Patient Registry
RECRUITING
-
NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
RECRUITING
-
Leucine in Midlife Depression
RECRUITING · Phase 2
-
Ketamine Alcohol (in Treatment-Resistant Depression)
RECRUITING · Phase 2
-
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04375033 · 952 participants · Phase 4
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
- NCT06225596 · 956 participants · Phase 2
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
- NCT03784924 · 950 participants
EDRN Prostate MRI Biomarker Study
- NCT04180930 · 950 participants
An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI